Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-1

doi:10.4239/wjd.v14.i2.110

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3914)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

162

WORD

HTML

1420

Figures (1-4)

459

Tables (1-3)

442

Sum=2504

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

181

Download

502

Sum=683

Publishing Process of This Article

Item

Count

Browse

199

Download

528

Sum=727

Feb 15, 2023 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Diabetes. Feb 15, 2023; 14(2): 110-119
Published online Feb 15, 2023. doi: 10.4239/wjd.v14.i2.110

Full Size Figure Download Figure

Figure 1 Weekly body weight and fasting blood glucose trend of rats in each group after liraglutide intervention. A: Weekly body weight; B: Fasting blood glucose trend. N: Normal control; M: Model; HL: High-dose liraglutide; LL: Low-dose liraglutide; FBG: Fasting blood glucose.

Citation: Xue DD, Zhang X, Li DW, Yang YL, Liu JJ. Protective effect of liraglutide on the myocardium of type 2 diabetic rats by inhibiting polyadenosine diphosphate-ribose polymerase-1. World J Diabetes 2023; 14(2): 110-119
URL: https://www.wjgnet.com/1948-9358/full/v14/i2/110.htm
DOI: https://dx.doi.org/10.4239/wjd.v14.i2.110